BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fassan M, Saraggi D, Balsamo L, Realdon S, Scarpa M, Castoro C, Coati I, Salmaso R, Farinati F, Guzzardo V, Arcidiacono D, Munari G, Gasparini P, Veronese N, Luchini C, Valeri N, Rugge M. Early miR-223 Upregulation in Gastroesophageal Carcinogenesis. Am J Clin Pathol. 2017;147:301-308. [PMID: 28395057 DOI: 10.1093/ajcp/aqx004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Ma J, Cao T, Cui Y, Zhang F, Shi Y, Xia J, Wang ZP. miR-223 Regulates Cell Proliferation and Invasion via Targeting PDS5B in Pancreatic Cancer Cells. Mol Ther Nucleic Acids 2019;14:583-92. [PMID: 30776580 DOI: 10.1016/j.omtn.2019.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhang N, Coutinho LE, Pati D. PDS5A and PDS5B in Cohesin Function and Human Disease. Int J Mol Sci 2021;22:5868. [PMID: 34070827 DOI: 10.3390/ijms22115868] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Battaglin F, Naseem M, Puccini A, Lenz HJ. Molecular biomarkers in gastro-esophageal cancer: recent developments, current trends and future directions. Cancer Cell Int. 2018;18:99. [PMID: 30008616 DOI: 10.1186/s12935-018-0594-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
4 Li L, Xing CJ, Cong L, Wan YZ. MiR-223-3p targets ECT2 to regulate cell cycle and apoptosis in gastric cancer cells. Shijie Huaren Xiaohua Zazhi 2018; 26(2): 71-79 [DOI: 10.11569/wcjd.v26.i2.71] [Reference Citation Analysis]
5 Ricciardiello F, Falco M, Tortoriello G, Riccardi F, Pellini R, Iorio B, Russo G, Longo G, Coppola C, Takeuchi T, Grimaldi A, Abate M, Scrima M, Cossu AM, Addeo R, Ottaiano A, Scarpa A, Boscaino A, Motta G, Caraglia M, Bocchetti M, Misso G. Poorly Differentiated Neuroendocrine Larynx Carcinoma: Clinical Features and miRNAs Signature-A New Goal for Early Diagnosis and Therapy? J Clin Med 2021;10:2019. [PMID: 34066893 DOI: 10.3390/jcm10092019] [Reference Citation Analysis]
6 Aalami AH, Pouresmaeil V, Amirabadi A, Mojahed FH, Rad MQ, Sahebkar A. Evaluation of the Diagnostic Properties of Serum hsa-miR-223-5p in the Detection of Gastric Cancer: A Case-Control Study. Anticancer Agents Med Chem 2020;20:800-8. [PMID: 32013852 DOI: 10.2174/1871520620666200204100602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Liu CM, Liang D, Jin J, Li DJ, Zhang YC, Gao ZY, He YT. Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma. Thorac Cancer 2017;8:549-57. [PMID: 28892299 DOI: 10.1111/1759-7714.12493] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lv J, Zhao HP, Dai K, Cheng Y, Zhang J, Guo L. Circulating exosomal miRNAs as potential biomarkers for Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol 2020; 26(22): 2889-2901 [PMID: 32587437 DOI: 10.3748/wjg.v26.i22.2889] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
9 Wei LJ, Li JA, Bai DM, Song Y. miR-223-RhoB signaling pathway regulates the proliferation and apoptosis of colon adenocarcinoma. Chem Biol Interact 2018;289:9-14. [PMID: 29660302 DOI: 10.1016/j.cbi.2018.04.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
10 Fassan M, Realdon S, Cascione L, Hahne JC, Munari G, Guzzardo V, Arcidiacono D, Lampis A, Brignola S, Dal Santo L, Agostini M, Bracon C, Maddalo G, Scarpa M, Farinati F, Zaninotto G, Valeri N, Rugge M. Circulating microRNA expression profiling revealed miR-92a-3p as a novel biomarker of Barrett's carcinogenesis. Pathol Res Pract 2020;216:152907. [PMID: 32131978 DOI: 10.1016/j.prp.2020.152907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Lee L, Howitt B, Cheng T, King M, Stawiski K, Fendler W, Chowdhury D, Matulonis U, Konstantinopoulos PA. MicroRNA profiling in a case-control study of African American women with uterine serous carcinoma. Gynecol Oncol 2021:S0090-8258(21)01384-6. [PMID: 34607711 DOI: 10.1016/j.ygyno.2021.09.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Vasapolli R, Venerito M, Schirrmeister W, Thon C, Weigt J, Wex T, Malfertheiner P, Link A. Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs. PLoS One 2021;16:e0249282. [PMID: 33857171 DOI: 10.1371/journal.pone.0249282] [Reference Citation Analysis]
13 Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives. World J Gastroenterol 2018; 24(30): 3313-3329 [PMID: 30122873 DOI: 10.3748/wjg.v24.i30.3313] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
14 Zarrilli G, Galuppini F, Angerilli V, Munari G, Sabbadin M, Lazzarin V, Nicolè L, Biancotti R, Fassan M. miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma. Int J Mol Sci 2021;22:3640. [PMID: 33807389 DOI: 10.3390/ijms22073640] [Reference Citation Analysis]
15 Wang H, Chen J, Zhang S, Zheng X, Xie S, Mao J, Cai Y, Lu X, Hu L, Shen J, Chai K, Chen W. MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer. Cancer Cell Int 2020;20:258. [PMID: 32577098 DOI: 10.1186/s12935-020-01284-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Favero A, Segatto I, Perin T, Belletti B. The many facets of miR-223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response. Wiley Interdiscip Rev RNA 2021;:e1659. [PMID: 33951281 DOI: 10.1002/wrna.1659] [Reference Citation Analysis]